Rifampin for Surgically Treated Staphylococcal Infective Endocarditis: A Propensity Score-Adjusted Cohort Study Nabin K. Shrestha, Shailee Y. Shah, Hannah Wang, Syed T. Hussain, Gosta B. Pettersson, Amy S. Nowacki, Steven M. Gordon The Annals of Thoracic Surgery Volume 101, Issue 6, Pages 2243-2250 (June 2016) DOI: 10.1016/j.athoracsur.2015.11.015 Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Propensity score overlap between patients treated with rifampin and those not treated. The Annals of Thoracic Surgery 2016 101, 2243-2250DOI: (10.1016/j.athoracsur.2015.11.015) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Balance in distribution of variables across rifampin usage groups before and after adjustment for propensity score. The Annals of Thoracic Surgery 2016 101, 2243-2250DOI: (10.1016/j.athoracsur.2015.11.015) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 3 Kaplan-Meier plot for reoperation-free survival for patients with and without rifampin treatment after operation for infective endocarditis (IE). The Annals of Thoracic Surgery 2016 101, 2243-2250DOI: (10.1016/j.athoracsur.2015.11.015) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions